151 related articles for article (PubMed ID: 31097100)
21. Thymic Epithelial Tumors phenotype relies on miR-145-5p epigenetic regulation.
Bellissimo T; Ganci F; Gallo E; Sacconi A; Tito C; De Angelis L; Pulito C; Masciarelli S; Diso D; Anile M; Petrozza V; Giangaspero F; Pescarmona E; Facciolo F; Venuta F; Marino M; Blandino G; Fazi F
Mol Cancer; 2017 May; 16(1):88. PubMed ID: 28486946
[TBL] [Abstract][Full Text] [Related]
22. Circulating miR-21-5p and miR-148a-3p as emerging non-invasive biomarkers in thymic epithelial tumors.
Bellissimo T; Russo E; Ganci F; Vico C; Sacconi A; Longo F; Vitolo D; Anile M; Disio D; Marino M; Blandino G; Venuta F; Fazi F
Cancer Biol Ther; 2016; 17(1):79-82. PubMed ID: 26575977
[TBL] [Abstract][Full Text] [Related]
23. Comparison of clinical features and survival between thymic carcinoma and thymic carcinoid patients.
Zhao Y; Gu H; Fan L; Han K; Yang J; Zhao H
Eur J Cardiothorac Surg; 2017 Jul; 52(1):33-38. PubMed ID: 28419205
[TBL] [Abstract][Full Text] [Related]
24. Diagnostic Roles of Immunohistochemistry in Thymic Tumors: Differentiation between Thymic Carcinoma and Thymoma.
Jeong JH; Pyo JS; Kim NY; Kang DW
Diagnostics (Basel); 2020 Jul; 10(7):. PubMed ID: 32640732
[No Abstract] [Full Text] [Related]
25. Diagnostic roles of MUC1 and GLUT1 in differentiating thymic carcinoma from type B3 thymoma.
Du MJ; Shen Q; Yin H; Rao Q; Zhou MX
Pathol Res Pract; 2016 Nov; 212(11):1048-1051. PubMed ID: 27688088
[TBL] [Abstract][Full Text] [Related]
26. [Correlation of amplification of chromosome 1 with histologic typing of thymic epithelial tumors].
Ma YQ; Zhang C; Cui WL; Gulinaer A; Zhang W; Wang J
Zhonghua Bing Li Xue Za Zhi; 2011 Dec; 40(12):820-4. PubMed ID: 22336207
[TBL] [Abstract][Full Text] [Related]
27. mRNA expression of IGF-1 and IGF-1R in patients with colorectal adenocarcinoma and type 2 diabetes.
Liu R; Hu LL; Sun A; Cao YJ; Tang T; Zhang XP; Zhang QH
Arch Med Res; 2014 May; 45(4):318-24. PubMed ID: 24751329
[TBL] [Abstract][Full Text] [Related]
28. Increased Galectin-1 Expression in Thymic Epithelial Tumors.
Riess JW; Kong CS; West RB; Padda SK; Neal JW; Wakelee HA; Le QT
Clin Lung Cancer; 2019 May; 20(3):e356-e361. PubMed ID: 30773448
[TBL] [Abstract][Full Text] [Related]
29. Significance of tumor mutation burden and immune infiltration in thymic epithelial tumors.
Wang ZM; Xu QR; Kaul D; Ismail M; Badakhshi H
Thorac Cancer; 2021 Jul; 12(13):1995-2006. PubMed ID: 34033229
[TBL] [Abstract][Full Text] [Related]
30. Expression of insulin-like growth factor 1 receptor (IGF-1R) predicts poor responses to epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors in non-small cell lung cancer patients harboring activating EGFR mutations.
Yeo CD; Park KH; Park CK; Lee SH; Kim SJ; Yoon HK; Lee YS; Lee EJ; Lee KY; Kim TJ
Lung Cancer; 2015 Mar; 87(3):311-7. PubMed ID: 25617986
[TBL] [Abstract][Full Text] [Related]
31. The presence of extrathoracic metastasis is more prognostic of survival than Masaoka stage (IVa/IVb) in metastatic thymic epithelial tumor: a retrospective cohort study.
Shin DY; Kim DW; Keam B; Kim TM; Lee SH; Kang CH; Kim YT; Heo DS
Lung Cancer; 2014 Aug; 85(2):320-5. PubMed ID: 24954359
[TBL] [Abstract][Full Text] [Related]
32. Impact of PD-L1, transforming growth factor-β expression and tumor-infiltrating CD8
Duan J; Liu X; Chen H; Sun Y; Liu Y; Bai H; Wang J
Thorac Cancer; 2018 Nov; 9(11):1341-1353. PubMed ID: 30168897
[TBL] [Abstract][Full Text] [Related]
33. Association of OCT4, SOX2, and NANOG expression with oral squamous cell carcinoma progression.
Fu TY; Hsieh IC; Cheng JT; Tsai MH; Hou YY; Lee JH; Liou HH; Huang SF; Chen HC; Yen LM; Tseng HH; Ger LP
J Oral Pathol Med; 2016 Feb; 45(2):89-95. PubMed ID: 26211876
[TBL] [Abstract][Full Text] [Related]
34. Molecular landscape of thymic epithelial tumors.
Prays J; Ortiz-Villalón C
Semin Diagn Pathol; 2022 Mar; 39(2):131-136. PubMed ID: 34272124
[TBL] [Abstract][Full Text] [Related]
35. Thymic epithelial tumors: Do we know all the prognostic factors?
Knetki-Wróblewska M; Kowalski DM; Olszyna-Serementa M; Krzakowski M; Szołkowska M
Thorac Cancer; 2021 Feb; 12(3):339-348. PubMed ID: 33386778
[TBL] [Abstract][Full Text] [Related]
36. Impact of IGF-1, IGF-1R, and IGFBP-3 promoter methylation on the risk and prognosis of esophageal carcinoma.
Ye P; Qu CF; Hu XL
Tumour Biol; 2016 May; 37(5):6893-904. PubMed ID: 26662570
[TBL] [Abstract][Full Text] [Related]
37. The Integrated Genomic Landscape of Thymic Epithelial Tumors.
Radovich M; Pickering CR; Felau I; Ha G; Zhang H; Jo H; Hoadley KA; Anur P; Zhang J; McLellan M; Bowlby R; Matthew T; Danilova L; Hegde AM; Kim J; Leiserson MDM; Sethi G; Lu C; Ryan M; Su X; Cherniack AD; Robertson G; Akbani R; Spellman P; Weinstein JN; Hayes DN; Raphael B; Lichtenberg T; Leraas K; Zenklusen JC; ; Fujimoto J; Scapulatempo-Neto C; Moreira AL; Hwang D; Huang J; Marino M; Korst R; Giaccone G; Gokmen-Polar Y; Badve S; Rajan A; Ströbel P; Girard N; Tsao MS; Marx A; Tsao AS; Loehrer PJ
Cancer Cell; 2018 Feb; 33(2):244-258.e10. PubMed ID: 29438696
[TBL] [Abstract][Full Text] [Related]
38. STAT3 expression correlates with prognosis of thymic epithelial tumors.
Li C; Wang Z; Liu Y; Wang P; Zhang R
J Cardiothorac Surg; 2013 Apr; 8():92. PubMed ID: 23590999
[TBL] [Abstract][Full Text] [Related]
39. Precise Diagnosis and Treatment of Thymic Epithelial Tumors Based on Molecular Biomarkers.
Du J; Zhou XJ
Crit Rev Oncog; 2017; 22(5-6):507-514. PubMed ID: 29604928
[TBL] [Abstract][Full Text] [Related]
40. Unraveling molecular networks in thymic epithelial tumors: deciphering the unique signatures.
Zhang X; Zhang P; Cong A; Feng Y; Chi H; Xia Z; Tang H
Front Immunol; 2023; 14():1264325. PubMed ID: 37849766
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
